Texas · House Bill 2529 · 88th Legislature, Regular Session

Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.

HB 2529 Sponsored by James Talarico Died in committee

  1. Introduced Feb 21, 2023
  2. In committee Mar 13, 2023
  3. Died  
  4. Passed the Senate  
  5. To the governor  
  6. Became law  

Every action

7 steps, oldest first, as the legislature records them.

  1. HouseFiled
  2. HouseRead first time
  3. CommitteeReferred to Public Health · House Public Health
  4. CommitteeScheduled for public hearing on . . . · House Public Health
  5. CommitteeConsidered in public hearing · House Public Health
  6. CommitteeTestimony taken/registration(s) recorded in committee · House Public Health
  7. CommitteeLeft pending in committee · House Public Health

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it.

From Texas's official records (ftp.legis.state.tx.us), checked Nov 13, 2026. Text links go to the official versions; LegiList does not copy bill text.